Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple SclerosisJAMA Netw Open 2022 Dec 01;5(12)e2248664, JB Smith, EG Gonzales, BH Li, A Langer-Gould
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.